Rosado J, Han J, Obadia T, Munro J, Traore Z, Schoffer K, Brewster J, Bourke C, Vinetz JM, White M, Bahlo M, Gamboa D, Mueller I, Ruybal-Pesántez S. Understanding Plasmodium vivax recurrent infections using an amplicon deep sequencing assay, PvAmpSeq, identity-by-descent and model-based classification. 2025;:10.1101/2025.05.26.25327775
Ciavarella C, Drakeley C, Price RN, Mueller I, White M. Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics. The Lancet Infectious Diseases. 2025;25(6):10.1016/s1473-3099(24)00689-3
França CT, Hostetler JB, Sharma S, White MT, Lin E, Kiniboro B, Waltmann A, Darcy AW, Li Wai Suen CSN, Siba P, King CL, Rayner JC, Fairhurst RM, Mueller I. Correction: An antibody screen of a Plasmodium vivax antigen library identifies novel merozoite proteins associated with clinical protection. PLOS Neglected Tropical Diseases. 2025;19(5):10.1371/journal.pntd.0013122
Bernal J, Macalinao ML, Cosca K, Boncayao B, Mueller I, Espino FEJ, Stresman G, Luchavez J, Longley RJ. Applying novel Plasmodium Vivax serological exposure markers to quantify residual malaria transmission in the Philippines through repeated health facility surveys: the SMaRT study protocol. BMC Infectious Diseases. 2025;25(1):10.1186/s12879-025-10934-2
Eriksson EM, Mueller I. Increased fatty acid production and macrophage‐driven inflammation as key drivers of severe respiratory disease. Immunology and Cell Biology. 2025;103(3):10.1111/imcb.12852
D J, Krauss L, Smith L, D’Andrea L, Chan L-J, Abraham A, Kiernan-Walker N, Mazhari R, Lamont M, Lim PS, Sattabongkot J, Lacerda MV, Wini L, Mueller I, Longley RJ, Pymm P, Fleishman SJ, Tham W-H. Stabilized designs of the malaria adhesin protein PvRBP2b for use as a potential diagnostic for Plasmodium vivax. Journal of Biological Chemistry. 2025;301(3):10.1016/j.jbc.2025.108290
Tacoli C, Thin S, Ea M, Khim N, Orban A, Lek D, Longley RJ, White M, Robinson LJ, Witkowski B, Mueller I, Popovici J. Evaluating the technical feasibility of serological testing and treatment for Plasmodium vivax in mobile at-risk of malaria Cambodian populations. The Lancet Regional Health – Western Pacific. 2025;56:10.1016/j.lanwpc.2025.101518
Tréhard H, Musset L, Lazrek Y, White M, Pelleau S, Mueller I, Djossou F, Sanna A, Landier J, Gaudart J, Mosnier E. Which diagnostic test to use for Testing and Treatment strategies in Plasmodium vivax low-transmission settings: a secondary analysis of a longitudinal interventional study. The Lancet Regional Health – Americas. 2024;38:10.1016/j.lana.2024.100883
Hu S, Wang F, Huang Q, Chen Y, Lyu D, Zhou N, Wang M, Zhang M, Xu C, Mueller I, Yao G, Liu X, Zhang Q, Hong W. Eveningness is associated with more severe depressive symptoms independently of sleep quality and fatigue level only in first-episode but not recurrent depression in major depressive disorder. Chronobiology International. 2024;41(7):10.1080/07420528.2024.2378958
Kosasih A, Utami RAS, Noviyanti R, Elyazar IRF, Lestari KD, Raimanus VS, Longley RJ, Baird JK, Robinson LJ, Sutanto I, Mueller I. Agreement between serological data on schoolchildren and the number of malaria cases in the remaining high-burden villages of Indonesia. Frontiers in Malaria. 2024;2:10.3389/fmala.2024.1362585